In addition, HuMax-IL8 was previously shown to decrease IL-8-induced neutrophil activation and migration in vitro, as well as beneficial anti-inflammatory responses in patients with palmoplantar pustulosis (PPP) [120]. This evidence concerns the gene CXCL8 and palmoplantar pustulosis.